Ulrike Hafner

612 total citations
7 papers, 470 citations indexed

About

Ulrike Hafner is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ulrike Hafner has authored 7 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Ulrike Hafner's work include Natural Compound Pharmacology Studies (2 papers), Retinoids in leukemia and cellular processes (1 paper) and Peptidase Inhibition and Analysis (1 paper). Ulrike Hafner is often cited by papers focused on Natural Compound Pharmacology Studies (2 papers), Retinoids in leukemia and cellular processes (1 paper) and Peptidase Inhibition and Analysis (1 paper). Ulrike Hafner collaborates with scholars based in Germany. Ulrike Hafner's co-authors include Wernér E.G. Müller, Melanie Rolli, Carolin Schäfer, Meinolf Wonnemann, A. Singer, S. Stoll, Bettina Kränzlin and Oliver Pohl and has published in prestigious journals such as Life Sciences, Neurobiology of Aging and Pharmacopsychiatry.

In The Last Decade

Ulrike Hafner

4 papers receiving 440 citations

Peers

Ulrike Hafner
Carolin Schäfer Switzerland
A. Singer Germany
Giuseppina Inferrera Italy
Irene Soeller United States
A Zangara Australia
M. Levi de Stein Argentina
A. V. Muruganandam India
Gwladys Temkou Ngoupaye Cameroon
K S Satyan India
Catrin Sinner Austria
Carolin Schäfer Switzerland
Ulrike Hafner
Citations per year, relative to Ulrike Hafner Ulrike Hafner (= 1×) peers Carolin Schäfer

Countries citing papers authored by Ulrike Hafner

Since Specialization
Citations

This map shows the geographic impact of Ulrike Hafner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Hafner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Hafner more than expected).

Fields of papers citing papers by Ulrike Hafner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Hafner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Hafner. The network helps show where Ulrike Hafner may publish in the future.

Co-authorship network of co-authors of Ulrike Hafner

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Hafner. A scholar is included among the top collaborators of Ulrike Hafner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Hafner. Ulrike Hafner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hafner, Ulrike. (2018). Neues zu Atezolizumab. 21(5). 78–78.
2.
3.
Hafner, Ulrike. (2016). Immuntherapie bei lokal fortgeschrittenem oder metastasiertem Urothelkarzinom. Im Focus Onkologie. 19(10). 72–72.
4.
Müller, Wernér E.G., A. Singer, Meinolf Wonnemann, et al.. (1998). Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract. Pharmacopsychiatry. 31(S 1). 16–21. 194 indexed citations
5.
Stoll, S., Ulrike Hafner, Bettina Kränzlin, & Wernér E.G. Müller. (1997). Chronic Treatment of Syrian Hamsters With Low-Dose Selegiline Increases Life Span in Females But Not Males. Neurobiology of Aging. 18(2). 205–211. 32 indexed citations
6.
Müller, Wernér E.G., Melanie Rolli, Carolin Schäfer, & Ulrike Hafner. (1997). Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant Activity. Pharmacopsychiatry. 30(S 2). 102–107. 220 indexed citations
7.
Stoll, S., Ulrike Hafner, Oliver Pohl, & Wernér E.G. Müller. (1994). Age-related memory decline and longevity under treatment with selegiline. Life Sciences. 55(25-26). 2155–2163. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolin Schäfer Breakdown of academic impact, for papers by A. Singer Breakdown of academic impact, for papers by Giuseppina Inferrera Breakdown of academic impact, for papers by Irene Soeller Breakdown of academic impact, for papers by A Zangara Breakdown of academic impact, for papers by M. Levi de Stein Breakdown of academic impact, for papers by A. V. Muruganandam Breakdown of academic impact, for papers by Gwladys Temkou Ngoupaye Breakdown of academic impact, for papers by K S Satyan Breakdown of academic impact, for papers by Catrin Sinner
Rankless by CCL
2026